Stocksigma LogoStocksigma Logo

Samsrita Labs Reports Q2 FY27 Results; Key Strategic Approvals Highlighted

Samsrita Labs reported standalone net loss of ₹11.61 lakhs with nil operational revenue for the quarter ended 30th Sep'26, compared to a net loss of

Samsrita Labs Reports Q2 FY27 Results; Key Strategic Approvals Highlighted

Samsrita Labs Ltd · Outcome · 11 Nov 2026, 10:43 pm

Samsrita Labs Reports Q2 FY27 Results; Key Strategic Approvals Highlighted Samsrita Labs reported standalone net loss of ₹11.61 lakhs with nil operational revenue for the quarter ended 30th Sep'26, compared to a net loss of ₹493.50 lakhs YoY. Consolidated net loss stood at ₹28.29 lakhs against a loss of ₹454.77 lakhs YoY. Key corporate developments approved include an investment up to ₹1.00 crore in CCPS of S Labs Hygiene Care, a material related-party sales transaction with the entity up to ₹25.00 crore, and an unsecured loan up to ₹1.00 crore at 9% interest from a director.

Original exchange filing (PDF)

More announcements from Samsrita Labs Ltd

All Samsrita Labs Ltd announcements